Literature DB >> 19940998

High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology.

Jean-Christophe Noël1, Isabelle Fayt, Maria Rosaria Romero Munoz, Philippe Simon, Corinne Engohan-Aloghe.   

Abstract

OBJECTIVE: To evaluate the risk of high-risk human papillomavirus (HPV) infection in women with Trichomonas vaginalis infection, and the reason remains unclear.
METHODS: A total of 40,000 liquid-based cytology specimens were tested from 2005 to 2008. Among these, high-risk HPV testing using the hybrid capture II assay was performed in positive cases of T. vaginalis according to the age of patients (<30 years old, between 30 and 50 years old, more than 50 years old). As controls, HPV detection was also performed in 450 normal smears.
RESULTS: T. vaginalis was found in 80 cases (0.2%). From these 80 cases, 57 were available for HPV testing (8 patients <30 years old, 42 patients between 30 and 50 years old and 7 patients more than 50 years old). As controls, high-risk HPV was tested in 150 patients with normal cytology for each of these three age categories. High-risk HPV was significantly more frequently detected in women with T. vaginalis than in women with normal smear irrespective of the categories of age (P < 0.01).
CONCLUSION: For the first time, we demonstrated a significant prevalence of high-risk HPV in women with cytological proved T. vaginalis infection independent of the age ranges. Our data suggest a potential association between these two infectious agents by the way of a sexual intercourse and probably by a biochemical or immunological reasons.

Entities:  

Mesh:

Year:  2009        PMID: 19940998     DOI: 10.1007/s00404-009-1291-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

1.  Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.

Authors:  Márcia Rodrigues Trein; Lígia Rodrigues E Oliveira; Graziela Vargas Rigo; Mayara Aparecida Rocha Garcia; Brenda Petro-Silveira; Danielle da Silva Trentin; Alexandre José Macedo; Luis Octávio Regasini; Tiana Tasca
Journal:  Parasitol Res       Date:  2018-12-07       Impact factor: 2.289

2.  The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Julio A Urbina; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2014-04-22       Impact factor: 2.289

3.  Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis.

Authors:  Tatiana Guinancio de Souza; Gustavo Benaim; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2022-04-18       Impact factor: 2.289

4.  Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2013-12-22       Impact factor: 2.289

5.  Novel structural features of the immunocompetent ceramide phospho-inositol glycan core from Trichomonas vaginalis.

Authors:  Christian Heiss; Zhirui Wang; Ian Black; Parastoo Azadi; Raina N Fichorova; Bibhuti N Singh
Journal:  Carbohydr Res       Date:  2015-11-10       Impact factor: 2.104

6.  Limitations on the detection rate of high-risk HPV by hybrid capture 2 methodology in high grade intraepithelial (HSIL) or atypical squamous cells-cannot exclude HSIL (ASC-H) cytological lesions with proved CIN2.

Authors:  Jean-Christophe Noël; Philippe Simon
Journal:  Anal Cell Pathol (Amst)       Date:  2015-09-02       Impact factor: 2.916

7.  Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing.

Authors:  Lixin Tao; Lili Han; Xia Li; Qi Gao; Lei Pan; Lijuan Wu; Yanxia Luo; Wei Wang; Zihe Zheng; Xiuhua Guo
Journal:  BMC Public Health       Date:  2014-11-19       Impact factor: 3.295

8.  Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population.

Authors:  Sonia Menon; Davy van den Broeck; Rodolfo Rossi; Emilomo Ogbe; Hillary Mabeya
Journal:  Infect Agent Cancer       Date:  2017-01-06       Impact factor: 2.965

9.  Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil.

Authors:  Ilka Kassandra Pereira Belfort; Ana Paula Almeida Cunha; Francisco Pedro Belfort Mendes; Leonardo Victor Galvão-Moreira; Renata Gaspar Lemos; Lucas Henrique de Lima Costa; Pablo Monteiro; Mariele Borges Ferreira; Gerusinete Rodrigues Bastos Dos Santos; Joyce Leal Costa; Alice de Sá Ferreira; Luiz Gustavo Oliveira Brito; Luciane Maria Oliveira Brito; Flávia Castello Branco Vidal; Sally Cristina Moutinho Monteiro
Journal:  BMC Womens Health       Date:  2021-04-23       Impact factor: 2.809

10.  Evaluation of Association between Vaginal Infections and High-Risk Human Papillomavirus Types in Female Sex Workers in Spain.

Authors:  C Rodriguez-Cerdeira; E Sanchez-Blanco; A Alba
Journal:  ISRN Obstet Gynecol       Date:  2012-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.